List of articles with "Biohaven"

Biohaven Q3 2025 Results

Biohaven Q3 2025 Results

USA Biohaven New Haven BHVN Opakalim
FDA Decision on VYGLXIA

FDA Decision on VYGLXIA

United States Biohaven New Haven Spinocerebellar Ataxia VYGLXIA
Biohaven Fraud Lawsuit

Biohaven Fraud Lawsuit

USA Los Angeles Schall Law Firm Securities Fraud Biohaven
Biohaven Securities Fraud

Biohaven Securities Fraud

USA New York Securities Fraud Rosen Law Firm Biohaven
Biohaven Investor Lawsuit

Biohaven Investor Lawsuit

USA Securities Fraud Bensalem Biohaven BHVN
Biohaven Class Action Alert

Biohaven Class Action Alert

USA New York Securities Law Biohaven Faruqi & Faruqi
Faruqi & Faruqi Alert

Faruqi & Faruqi Alert

United States New York Biohaven Faruqi & Faruqi BHVN
Biohaven Investors Lead Case

Biohaven Investors Lead Case

United States New York Class Action Securities Fraud Biohaven
Class Action Against Biohaven

Class Action Against Biohaven

United States New York Class Action Biohaven Pomerantz Law
Biohaven's Financial Highlights

Biohaven's Financial Highlights

United States Biohaven New Haven BHV-8000 VYGLXIA
Biohaven Investigation

Biohaven Investigation

USA New York Securities Law Biohaven Faruqi & Faruqi
Biohaven Investors Lawsuit

Biohaven Investors Lawsuit

None Securities Fraud Biohaven BHVN
Biohaven Investors Alert

Biohaven Investors Alert

USA Los Angeles Schall Law Firm Securities Fraud Biohaven
Biohaven Investors Alert

Biohaven Investors Alert

United States New York Lawsuit Biohaven Faruqi & Faruqi
Parkinson's Trial Launch

Parkinson's Trial Launch

United States Biohaven New Haven Parkinson's Disease BHV-8000
Biohaven R&D Day Highlights

Biohaven R&D Day Highlights

USA Biohaven New Haven IgA nephropathy BHV-1400
Biohaven Oncology Updates

Biohaven Oncology Updates

USA Cancer Treatments Biohaven New Haven antibody drug conjugates
FDA Extends Biohaven Review

FDA Extends Biohaven Review

United States Biohaven New Haven Troriluzole Biohaven Ltd
Biohaven Q1 2025 Milestones

Biohaven Q1 2025 Milestones

United States Biohaven New Haven Troriluzole Oberland Capital
Biohaven Invests in Troriluzole

Biohaven Invests in Troriluzole

United States Biohaven New Haven BHVN Oberland Capital
Biohaven at AAN 2025

Biohaven at AAN 2025

USA San Diego Biohaven Neurology AAN2025
Biohaven 2024 Highlights

Biohaven 2024 Highlights

USA Biohaven New Haven BHV-1300 Troriluzole
BHV-1300 Shows Promise

BHV-1300 Shows Promise

USA Biohaven New Haven BHV-1300 Graves' Disease
Troriluzole Breakthrough

Troriluzole Breakthrough

United States Biohaven New Haven Troriluzole Spinocerebellar Ataxia
Biohaven at J.P. Morgan

Biohaven at J.P. Morgan

USA healthcare Biohaven New Haven BHV-1400
Biohaven at J.P. Morgan

Biohaven at J.P. Morgan

United States San Francisco Biohaven J.P. Morgan Vlad Coric
Biohaven's Phase 1 Breakthrough

Biohaven's Phase 1 Breakthrough

United States Biohaven New Haven BHV-1300 IgG Therapy
BHV-7000 at AES 2024

BHV-7000 at AES 2024

USA Los Angeles Biohaven Epilepsy BHV-7000
Taldefgrobep Alpha Update

Taldefgrobep Alpha Update

USA Biohaven Taldefgrobep Alpha SMA New Haven

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.